Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
Recruiting · NCT05736367 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-01-21 | NCT05736367 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ludwig Institute for Cancer Research | 4 |
| Rutgers, The State University of New Jersey | 154 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rutgers Cancer Institute of New Jersey | New Brunswick | United States | 223 |
| RWJBarnabas Health | New Brunswick | United States | 1 |